SMAC

SMAC

SMAC 詳細

Molecule Name
Diablo homolog, mitochondrial
分子の別称
DIABLO,SMAC
Drug Development Progress
治験薬の数1
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
Direct IAP-binding protein with low pI,Second mitochondria-derived activator of caspase,Smac,Diablo IAP-Binding Mitochondrial Protein
バックグランド
Diablo homolog, mitochondrial (DIABLO) is also known as direct IAP-binding protein with low pI and second mitochondria-derived activator of caspase (SMAC), which can interact with BIRC2/c-IAP1, BIRC3/c-IAP2, XIAP/BIRC4, BIRC6/bruce and BIRC7/livin. Acting by opposing the inhibitory activity of inhibitor of apoptosis proteins (IAP),DIABLO can also promote apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway. Also, DIABLO inhibits the activity of BIRC6/bruce by inhibiting its binding to caspases. Furthermore, DIABLO is defective in the capacity to down-regulate the XIAP/BIRC4 abundance.

SMAC 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
BI-891065BI-891065Phase 1 ClinicalBoehringer Ingelheim International Gmbh
Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Neoplasms
詳細